Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae
Clinical trial NCT02583373 · COMPLETED
Trial details
- NCT number
- NCT02583373
- Sponsor
- Combioxin SA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-21
- Primary completion
- 2018-02-20
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.